Overview
Stephen Oh is a Hematologist and a Public Health and Preventive Medicine provider in Saint Louis, Missouri. Dr. Oh and is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Polycythemia Vera, and Pancreaticoduodenectomy. Dr. Oh is currently accepting new patients.
His clinical research consists of co-authoring 179 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles and participated in 2 clinical trials in the study of Essential Thrombocythemia.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Cigna
- Cox Health
- Humana
Locations
4921 Parkview Pl, Saint Louis, MO 63110
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
Washington University
Amy Zhou is a Hematologist in Saint Louis, Missouri. Dr. Zhou has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Essential Thrombocythemia, Myelodysplastic Syndrome (MDS), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome. Dr. Zhou is currently accepting new patients.
Washington University
Morey Blinder is a Hematologist and a Transfusion Medicine provider in Saint Louis, Missouri. Dr. Blinder and is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Anaplastic Large Cell Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Thrombectomy.
Van Amburg And Busiek Mds LLC
Mark Fesler is a Hematologist Oncology specialist and a Transplant Surgeon in Chesterfield, Missouri. Dr. Fesler and is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant. Dr. Fesler is currently accepting new patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Castleman Disease
- Essential Thrombocythemia
- Multicentric Castleman Disease (MCD)
- Polycythemia Vera
- Systemic Mastocytosis
- Unicentric Castleman Disease (UCD)
- Advanced
- Acute Eosinophilic Pneumonia
- Acute Myeloid Leukemia (AML)
- Anemia
- Aplastic Anemia
- Chronic Myelogenous Leukemia (CML)
- Hypereosinophilic Syndrome
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Agranulocytosis
- Blood Clots
- Budd-Chiari Syndrome